| 1 |
Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
Jan B. Vermorken, Ricard Mesı́a, Fernando Rivera et al. · New England Journal of Medicine
Open access |
10 Sep 2008 |
3,762 |
| 2 |
Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis
Uri A. Liberman, Stuart R. Weiss, Johann Bröll et al. · New England Journal of Medicine
|
30 Nov 1995 |
2,304 |
| 3 |
Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer
Jan Baptist Vermorken, Éva Remenár, Carla van Herpen et al. · New England Journal of Medicine
Open access |
24 Oct 2007 |
1,726 |
| 4 |
Prognostic Significance of Tumor Regression After Preoperative Chemoradiotherapy for Rectal Cancer
Claus Michael Rödel, Peter Martus, Thomas Papadoupolos et al. · Journal of Clinical Oncology
|
26 Oct 2005 |
1,227 |
| 5 |
EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 Guidelines
Johannes Alfred Witjes, Éva Compérat, Nigel C. Cowan et al. · European Urology
|
12 Dec 2013 |
1,014 |
| 6 |
EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction
Christian Gratzke, Alexander Bachmann, A. Descazeaud et al. · European Urology
|
19 Jan 2015 |
1,012 |
| 7 |
Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigen
Eric Lancaster, Meizan Lai, Xiaoyu Peng et al. · The Lancet Neurology
Open access |
4 Dec 2009 |
927 |
| 8 |
Intravenous Zoledronic Acid in Postmenopausal Women with Low Bone Mineral Density
Ian R. Reid et al. · New England Journal of Medicine
Open access |
28 Feb 2002 |
877 |
| 9 |
A Systematic Review and Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Obstruction: An Update
Jean-Nicolas Cornu, Sascha Ahyai, Alexander Bachmann et al. · European Urology
Review |
25 Jun 2014 |
818 |
| 10 |
Randomized Phase II/III Trial Assessing Gemcitabine/Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer Who Are Unfit for Cisplatin-Based Chemotherapy: EORTC Study 30986
Maria De Santis, Joaquim Bellmunt, Graham M. Mead et al. · Journal of Clinical Oncology
Open access |
13 Dec 2011 |
787 |
| 11 |
Adjuvant Procarbazine, Lomustine, and Vincristine Improves Progression-Free Survival but Not Overall Survival in Newly Diagnosed Anaplastic Oligodendrogliomas and Oligoastrocytomas: A Randomized European Organisation for Research and Treatment of Cancer Phase III Trial
Martin J. van den Bent, Alain Carpentier, Alba Ariela Brandes et al. · Journal of Clinical Oncology
|
16 Jun 2006 |
750 |
| 12 |
Treatment of Muscle-invasive and Metastatic Bladder Cancer: Update of the EAU Guidelines
Arnulf Stenzl, Nigel C. Cowan, Maria De Santis et al. · European Urology
|
May 2011 |
679 |
| 13 |
The Updated EAU Guidelines on Muscle-Invasive and Metastatic Bladder Cancer
Arnulf Stenzl, Nigel C. Cowan, Maria De Santis et al. · European Urology
|
14 Jan 2009 |
644 |
| 14 |
European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I
S. Krege et al. · European Urology
|
14 Jan 2008 |
618 |
| 15 |
Chemotherapy‐induced neuropathy
Anthony J. Windebank, Wolfgang Grisold · Journal of the Peripheral Nervous System
|
Mar 2008 |
614 |
| 16 |
Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-third Dose Versus Full Dose and 1 Year Versus 3 Years of Maintenance
Jorg Reinier Oddens, Maurizio A. Brausi, Richard J Sylvester et al. · European Urology
|
2 Nov 2012 |
523 |
| 17 |
Extragonadal Germ Cell Tumors of the Mediastinum and Retroperitoneum: Results From an International Analysis
Carsten Bokemeyer, Craig R. Nichols, J P Droz et al. · Journal of Clinical Oncology
|
Apr 2002 |
508 |
| 18 |
Guidelines on management of low‐grade gliomas: report of an EFNS–EANO* Task Force
Riccardo Soffietti, Brigitta G. Baumert, Lorenzo Bello et al. · European Journal of Neurology
Open access |
16 Aug 2010 |
506 |
| 19 |
Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention
Wolfgang Grisold, Guido Cavaletti, Anthony J. Windebank · Neuro-Oncology
Open access |
Sep 2012 |
495 |
| 20 |
Association between ultrasound measurements of muscle thickness, pennation angle, echogenicity and skeletal muscle strength in the elderly
Eva-Maria Strasser, Thomas Draskovits, Markus Praschak et al. · AGE
Open access |
2 Mar 2013 |
447 |
| 21 |
Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes
Johannes R. Lemke et al. · Nature Genetics
|
11 Aug 2013 |
446 |
| 22 |
Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder
Richard J Sylvester, Maurizio A. Brausi, Wim J. Kirkels et al. · European Urology
Open access |
19 Dec 2009 |
439 |
| 23 |
Human recombinant soluble ACE2 in severe COVID-19
Alexander Zoufaly, Marko Poglitsch, Judith Helene Aberle et al. · The Lancet Respiratory Medicine
Open access |
24 Sep 2020 |
432 |
| 24 |
Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial
Cora Nanette Sternberg et al. · The Lancet Oncology
|
11 Dec 2014 |
390 |
| 25 |
Refining the prognostic impact of functional mitral regurgitation in chronic heart failure
Georg Goliasch, Philipp E Bartko, Noémi Pávó et al. · European Heart Journal
|
28 Jun 2017 |
359 |
| 26 |
Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study
Klaus‐Peter Dieckmann et al. · Journal of Clinical Oncology
Open access |
15 Mar 2019 |
354 |
| 27 |
Pathophysiology of Benign Prostatic Hyperplasia and Benign Prostatic Enlargement: A Mini-Review
Stephan Madersbacher, Natalie Sampson, Zoran Čulig · Gerontology
Review |
2019 |
353 |
| 28 |
Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up
Joaquim Bellmunt, Anna Orsola, Jeffrey Jia Jun Leow et al. · Annals of Oncology
Open access |
6 Aug 2014 |
340 |
| 29 |
EFNS guidelines on the diagnosis and management of orthostatic hypotension
Heinz Lahrmann, Pietro Cortelli, Max Josef Hilz et al. · European Journal of Neurology
Open access |
17 Jul 2006 |
336 |
| 30 |
Rickettsia africae,a Tick-Borne Pathogen in Travelers to Sub-Saharan Africa
Didier Raoult, Pierre‐Edouard Fournier, Florence Fenollar et al. · New England Journal of Medicine
|
17 May 2001 |
326 |
| 31 |
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015
Silke Gillessen et al. · Annals of Oncology
Open access |
4 Jun 2015 |
324 |
| 32 |
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer
J. Beyer et al. · Annals of Oncology
Open access |
14 Nov 2012 |
323 |
| 33 |
Presence of a p53 Gene Deletion in Patients With Multiple Myeloma Predicts for Short Survival After Conventional-Dose Chemotherapy
Johannes W. Drach, Jutta Ackermann, Elke Fritz et al. · Blood
|
Aug 1998 |
322 |
| 34 |
Laryngeal Recurrent Nerve Injury in Surgery for Benign Thyroid Diseases
Martin Hermann, Gunter Alk, Rudolf Roka et al. · Annals of Surgery
Open access |
Feb 2002 |
318 |
| 35 |
Maintenance Bacillus Calmette-Guerin for Ta T1 Bladder Tumors Is Not Associated with Increased Toxicity: Results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial
Adrian P.M. van der Meijden, Richard J Sylvester, Wim Oosterlinck et al. · European Urology
|
31 Jul 2003 |
306 |
| 36 |
Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt
Bernhard Angermayr, M Cejna, F Karnel et al. · Gut
Open access |
9 May 2003 |
294 |
| 37 |
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings
Guido Cavaletti et al. · Annals of Oncology
Open access |
22 Aug 2012 |
292 |
| 38 |
Incidence and outcome of weaning from mechanical ventilation according to new categories
G-C. Funk, Shilo H. Anders, M.-K. Breyer et al. · European Respiratory Journal
Open access |
18 Jun 2009 |
278 |
| 39 |
Reoperation, Myocardial Infarction and Mortality after Transurethral and Open Prostatectomy: A Nation-Wide, Long-Term Analysis of 23,123 Cases
Stephan Madersbacher, Jakob E. Lackner, Clemens Brössner et al. · European Urology
|
5 Jan 2005 |
276 |
| 40 |
Neuromonitoring in Thyroid Surgery
Martin Hermann, Christa Hellebart, Michael Freissmuth · Annals of Surgery
Open access |
22 Jun 2004 |
266 |
| 41 |
Prevalence of self‐reported neuropathic pain and impact on quality of life: a prospective representative survey
Burkhard Gustorff, Thomas Ernst Dorner, Rudolf Likar et al. · Acta Anaesthesiologica Scandinavica
|
Nov 2007 |
266 |
| 42 |
Gastric Interleukin‐8 and IgA IL‐8 Autoantibodies in Helicobacter pylori Infection
J. E. Crabtree, P. Peichl, J I Wyatt et al. · Scandinavian Journal of Immunology
|
1993 |
263 |
| 43 |
A consensus review on the development of palliative care for patients with chronic and progressive neurological disease
David J. Oliver, Gian Domenico Borasio, Augusto Tommaso Caraceni et al. · European Journal of Neurology
Open access |
Oct 2015 |
262 |
| 44 |
Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2
Alexandra Mihaela Popa et al. · Science Translational Medicine
Open access |
23 Nov 2020 |
261 |
| 45 |
Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1–3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with FGFR3 Alterations
Sumanta Kumar Pal et al. · Cancer Discovery
Open access |
30 May 2018 |
260 |
| 46 |
Peginterferon Alfa-2a and Ribavirin for 24 Weeks in Hepatitis C Type 1 and 4 Patients With Rapid Virological Response
Péter Ferenci, Hermann Laferl, Thomas–Matthias Scherzer et al. · Gastroenterology
|
18 Apr 2008 |
253 |
| 47 |
Bladder cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Joaquim Bellmunt, Anna Orsola, Thomas Wiegel et al. · Annals of Oncology
Open access |
Sep 2011 |
250 |
| 48 |
Sex and gender differences in chronic kidney disease: progression to end-stage renal disease and haemodialysis
Gabriela León Cobo, Manfred Hecking, Friedrich K. Port et al. · Clinical Science
|
Jun 2016 |
241 |
| 49 |
Pharmacokinetics of a novel anticancer ruthenium complex (KP1019, FFC14A) in a phase I dose-escalation study
Frederike Lentz, Anne Drescher, Andreas Lindauer et al. · Anti-Cancer Drugs
|
5 Jan 2009 |
241 |
| 50 |
Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients
Robert Königsberg, Eva Obermayr, Giovanna Bises et al. · Acta Oncologica
Open access |
24 Jan 2011 |
240 |